0001062993-23-009156.txt : 20230413
0001062993-23-009156.hdr.sgml : 20230413
20230413180948
ACCESSION NUMBER: 0001062993-23-009156
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221130
FILED AS OF DATE: 20230413
DATE AS OF CHANGE: 20230413
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: PAVmed Inc.
CENTRAL INDEX KEY: 0001624326
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40901
FILM NUMBER: 23819349
BUSINESS ADDRESS:
STREET 1: 360 MADISON AVENUE
STREET 2: 25TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10017
BUSINESS PHONE: (212) 949-4319
MAIL ADDRESS:
STREET 1: 360 MADISON AVENUE
STREET 2: 25TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10017
FORMER NAME:
FORMER CONFORMED NAME: PAXmed Inc.
DATE OF NAME CHANGE: 20141105
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Lucid Diagnostics Inc.
CENTRAL INDEX KEY: 0001799011
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 825488042
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 360 MADISON AVENUE
STREET 2: 25TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10017
BUSINESS PHONE: 212 949 4319
MAIL ADDRESS:
STREET 1: 360 MADISON AVENUE
STREET 2: 25TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10017
4/A
1
form4a.xml
AMENDED STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
X0407
4/A
2022-11-30
2022-12-02
0001799011
Lucid Diagnostics Inc.
LUCD
0001624326
PAVmed Inc.
360 MADISON AVENUE, 25TH FLOOR
NEW YORK
NY
10017
0
0
1
0
0
Common stock
2022-11-30
4
J
0
1145086
1.8383
A
29072276
D
Common Stock
2022-11-30
4
J
0
197656
2.7826
A
29269932
D
Common Stock
2022-11-30
4
J
0
221952
2.4780
A
29491884
D
Common Stock
2022-11-30
4
J
0
331210
1.6606
A
29823094
D
Common Stock
2022-11-30
4
J
0
1479326
1.8383
A
31302420
D
Issuance of common stock by the Issuer to the Reporting Person in satisfaction of a commercial agreement.
This Form 4 Amendment is being filed for the sole purpose of correcting the Amount of Securities Beneficially Owned Following Reported Transactions in Column 5 of Table I. In every other regard, this Form 4/A is identical to the Form 4 filed on December 2, 2022.
/s/ Dennis M. McGrath, as Secretary of the Reporting Person
2023-04-13